{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:05:45Z","timestamp":1784847945159,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atrial fibrillation (AF) screening after ischemic stroke or transient ischemic attack (TIA) is given high priority in clinical guidelines. However, patient selection, electrocardiogram (ECG) modality and screening duration remains undecided and current recommendations vary.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of this study was to investigate the clinical practice of AF screening after ischemic stroke or TIA at Swedish stroke units. In collaboration with the stakeholders of <jats:italic>the Swedish Stroke Register<\/jats:italic> (Riksstroke) a digital survey was drafted, then tested and revised by three stroke consultants. The survey consisted of 17 multiple choice\/ free text questions and was sent by e-mail to the medical directors at all stroke units in Sweden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All 72 stroke units in Sweden responded to the survey. Most stroke units reported that \u2265\u200975% of ischemic stroke (69\/72 stroke units) or TIA patients (67\/72 stroke units), without previously known AF, were screened for AF. Inpatient telemetry ECG was the method of first-choice in 81% of the units, but 7% reported lack of access. A variety of standard monitoring durations were used for inpatient telemetry ECG. The second most common choice was Holter ECG (17%), also with considerable variations in monitoring duration. Other AF screening modalities were used as a first-choice method (handheld and patch ECG) but less frequently.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinical practice for AF screening after ischemic stroke or TIA differed between Swedish stroke units, both in choice of AF screening methods as well as in monitoring durations. There is an urgent need for evidence and evidence-based recommendations in this field.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Not applicable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-024-03622-2","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:02:09Z","timestamp":1712822529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Large variations in atrial fibrillation screening practice after ischemic stroke and transient ischemic attack in Sweden: a survey study"],"prefix":"10.1186","volume":"24","author":[{"given":"Kajsa","family":"Str\u00e5\u00e5t","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Charlotte","family":"Laska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Rooth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Svennberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signild","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Engdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of AF SPICE steering committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"3622_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","volume":"120","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120:439\u201348. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308413.","journal-title":"Circ Res"},{"key":"3622_CR2","doi-asserted-by":"publisher","first-page":"CD000197","DOI":"10.1002\/14651858.CD000197.pub4","volume":"4","author":"P Langhorne","year":"2020","unstructured":"Langhorne P, Ramachandra S, Stroke Unit Trialists C. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database Syst Rev. 2020;4:CD000197. https:\/\/doi.org\/10.1002\/14651858.CD000197.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"3622_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/01.STR.0000115935.76330.24","volume":"35","author":"AG Rudd","year":"2004","unstructured":"Rudd AG, Matchar DB. Health policy and outcome research in stroke. Stroke. 2004;35:397\u2013400. https:\/\/doi.org\/10.1161\/01.STR.0000115935.76330.24.","journal-title":"Stroke"},{"key":"3622_CR4","unstructured":"Riksstroke. General information, https:\/\/www.riksstroke.org\/general-information\/ (accessed 2023-04-28)."},{"key":"3622_CR5","unstructured":"Riksstroke. Quality of the Swedish stroke care 2021, a brief summary of data for the full year 2021., https:\/\/www.riksstroke.org\/wp-content\/uploads\/2022\/11\/Arsrapport-2021-engelsk-sammanfattning_final.pdf (accessed 2023-04-28)."},{"key":"3622_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983\u20138. https:\/\/doi.org\/10.1161\/01.STR.22.8.983.","journal-title":"Stroke"},{"key":"3622_CR7","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","volume":"44","author":"S Bjorck","year":"2013","unstructured":"Bjorck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44:3103\u2013310820130827. https:\/\/doi.org\/10.1161\/STROKEAHA.113.002329.","journal-title":"Stroke"},{"key":"3622_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115\u20139. https:\/\/doi.org\/10.1161\/01.STR.0000166053.83476.4a.","journal-title":"Stroke"},{"key":"3622_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367. https:\/\/doi.org\/10.7326\/0003-4819-146-12-200706190-00007.","journal-title":"Ann Intern Med"},{"key":"3622_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","volume":"149","author":"GC Flaker","year":"2005","unstructured":"Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation follow-up investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149:657\u201363. https:\/\/doi.org\/10.1016\/j.ahj.2004.06.032.","journal-title":"Am Heart J"},{"key":"3622_CR11","unstructured":"Royal College of Physicians. National clinical guideline for stroke, Full 2016 guideline, https:\/\/www.strokeaudit.org\/Guideline\/Full-Guideline.aspx (accessed 2023-05-03)."},{"key":"3622_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","volume":"27","author":"NCAFGW Group","year":"2018","unstructured":"Group NCAFGW, Brieger D, Amerena J, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of Atrial Fibrillation 2018. Heart Lung Circ. 2018;27:1209\u201366. https:\/\/doi.org\/10.1016\/j.hlc.2018.06.1043.","journal-title":"Heart Lung Circ"},{"key":"3622_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"3622_CR14","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke 2021; 52: e364-e467. 20210524. https:\/\/doi.org\/10.1161\/STR.0000000000000375.","DOI":"10.1161\/STR.0000000000000375"},{"key":"3622_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/cjn.2021.127","volume":"49","author":"DJ Gladstone","year":"2022","unstructured":"Gladstone DJ, Lindsay MP, Douketis J, et al. Canadian stroke best practice recommendations: secondary Prevention of Stroke Update 2020. Can J Neurol Sci. 2022;49:315\u201333720210618. https:\/\/doi.org\/10.1017\/cjn.2021.127.","journal-title":"Can J Neurol Sci"},{"key":"3622_CR16","doi-asserted-by":"publisher","unstructured":"Rubiera M, Aires A, Antonenko K et al. European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. Eur Stroke J 2022; 7: VI. 20220603. https:\/\/doi.org\/10.1177\/23969873221099478.","DOI":"10.1177\/23969873221099478"},{"issue":"20180427","key":"3622_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00392-018-1256-9","volume":"107","author":"KG Haeusler","year":"2018","unstructured":"Haeusler KG, Groschel K, Kohrmann M, et al. Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol. 2018;107(20180427):871\u201380. https:\/\/doi.org\/10.1007\/s00392-018-1256-9.","journal-title":"Clin Res Cardiol"},{"key":"3622_CR18","unstructured":"Socialstyrelsen. Nationella riktlinjer f\u00f6r v\u00e5rd vid stroke, https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/nationella-riktlinjer\/2020-1-6545.pdf (accessed 2022-06-22)."},{"key":"3622_CR19","doi-asserted-by":"publisher","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 2019; 50: e344-e418. 20191030. https:\/\/doi.org\/10.1161\/STR.0000000000000211.","DOI":"10.1161\/STR.0000000000000211"},{"key":"3622_CR20","doi-asserted-by":"publisher","unstructured":"Ahmed N, Audebert H, Turc G et al. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11\u201313 November 2018. Eur Stroke J 2019; 4: 307\u2013317. 20190902. https:\/\/doi.org\/10.1177\/2396987319863606.","DOI":"10.1177\/2396987319863606"},{"key":"3622_CR21","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478\u201386. https:\/\/doi.org\/10.1056\/NEJMoa1313600.","journal-title":"N Engl J Med"},{"key":"3622_CR22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467\u201377. https:\/\/doi.org\/10.1056\/NEJMoa1311376.","journal-title":"N Engl J Med"},{"key":"3622_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","volume":"16","author":"R Wachter","year":"2017","unstructured":"Wachter R, Groschel K, Gelbrich G, et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol. 2017;16:282\u201390. https:\/\/doi.org\/10.1016\/S1474-4422(17)30002-9.","journal-title":"Lancet Neurol"},{"key":"3622_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(21)00067-3","volume":"20","author":"KG Haeusler","year":"2021","unstructured":"Haeusler KG, Kirchhof P, Kunze C, et al. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Lancet Neurol. 2021;20:426\u201336. https:\/\/doi.org\/10.1016\/S1474-4422(21)00067-3.","journal-title":"Lancet Neurol"},{"key":"3622_CR25","doi-asserted-by":"publisher","unstructured":"Tsivgoulis G, Triantafyllou S, Palaiodimou L et al. Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis. Neurology 2022; 98: e1942-e1952. 20220309. https:\/\/doi.org\/10.1212\/WNL.0000000000200227.","DOI":"10.1212\/WNL.0000000000200227"},{"key":"3622_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(23)00326-5","volume":"23","author":"LA Sposato","year":"2024","unstructured":"Sposato LA, Field TS, Schnabel RB, et al. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2024;23:110\u201312220231012. https:\/\/doi.org\/10.1016\/S1474-4422(23)00326-5.","journal-title":"Lancet Neurol"},{"key":"3622_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/104973239300300403","volume":"3","author":"ME Fonteyn","year":"1993","unstructured":"Fonteyn ME, Kuipers B, Grobe SJ. A description of think aloud Method and Protocol Analysis. Qual Health Res. 1993;3:430\u201341. https:\/\/doi.org\/10.1177\/104973239300300403.","journal-title":"Qual Health Res"},{"key":"3622_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/STROKEAHA.114.007212","volume":"46","author":"K Asplund","year":"2015","unstructured":"Asplund K, Sukhova M, Wester P, et al. Diagnostic procedures, treatments, and outcomes in stroke patients admitted to different types of hospitals. Stroke. 2015;46:806\u201381220150205. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007212.","journal-title":"Stroke"},{"key":"3622_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5853\/jos.2019.01067","volume":"21","author":"G Tsivgoulis","year":"2019","unstructured":"Tsivgoulis G, Katsanos AH, Kohrmann M, et al. Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in ischemic stroke patients: a systematic review and Meta-analysis. J Stroke. 2019;21:302\u201311. https:\/\/doi.org\/10.5853\/jos.2019.01067.","journal-title":"J Stroke"},{"key":"3622_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/ijs.12509","volume":"10","author":"M Giruparajah","year":"2015","unstructured":"Giruparajah M, Bosch J, Vanassche T, et al. Global survey of the diagnostic evaluation and management of cryptogenic ischemic stroke. Int J Stroke. 2015;10:1031\u20136. https:\/\/doi.org\/10.1111\/ijs.12509.","journal-title":"Int J Stroke"},{"key":"3622_CR31","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/STROKEAHA.115.009374","volume":"46","author":"T Rizos","year":"2015","unstructured":"Rizos T, Quilitzsch A, Busse O, et al. Diagnostic work-up for detection of paroxysmal atrial fibrillation after acute ischemic stroke: cross-sectional survey on German stroke units. Stroke. 2015;46:1693\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009374.","journal-title":"Stroke"},{"key":"3622_CR32","doi-asserted-by":"publisher","unstructured":"Lyckhage LF, Hansen ML, Butt JH et al. Time trends and patient selection in the use of continuous electrocardiography for detecting atrial fibrillation after stroke: a nationwide cohort study. Eur J Neurol 2020; 27: 2191\u20132201. 20200726. https:\/\/doi.org\/10.1111\/ene.14418.","DOI":"10.1111\/ene.14418"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03622-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03622-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03622-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:03:42Z","timestamp":1712822622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03622-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3622"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03622-2","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was revised by the Swedish Ethical Review Authority and the study was waived ethical approval (approval number 2021\u201305109). The study was performed in accordance with relevant guidelines and regulations. No sensitive health data were collected. All data collected were general information about clinical practice for AF screening at the stroke unit. Participation in the survey was voluntary. Invitation to participate in the survey was sent with <i>the Swedish stroke register<\/i> as one of the senders. The cover letter informed the recipients that the survey was done to facilitate the planning of a national multicenter register based randomised controlled trial about AF screening after ischemic stroke or TIA (AF-SPICE, Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events). Recipients were also informed that the results may be presented and published (without risk for identification of individual stroke units). The need for informed consent was waived by the Swedish Ethical Review Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KS reports scholarship from Swedish society of cardiology\/Boehringer- Ingelheim.\u00a0EI, ACL, ER - The authors declare that they have no competing interests.\u00a0ES reports institutional consultancy\/ lecture fees from Bayer, Bristol-Myers Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.\u00a0S\u00c5 reports lecture fees paid to the institution from Bristol-Myers Squibb, Pfizer, Boehringer-Ingelheim, and is a member of the steering committee of the Swedish Stroke Register (Riksstroke).\u00a0PW reports consultancy fees from Abbott and is a member of the steering committee of the Swedish Stroke Register (Riksstroke).\u00a0JE reports consultancy\/ lecture fees from Pfizer, Roche Diagnostics, Piotrode and Philips.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}